How do you treat bleeding disorders with desmopressin?
- 1 March 2007
- journal article
- review article
- Published by Oxford University Press (OUP)
- Vol. 83 (977), 159-163
- https://doi.org/10.1136/pgmj.2006.052118
Abstract
Desmopressin is an analog of vasopressin that exerts a substantial haemostatic effect by inducing the release of von Willebrand factor from its storage sites in endothelial cells. It has proved useful in treating or preventing bleeding episodes in patients with von Willebrand disease, haemophilia A and platelet function defects. Its efficacy in achieving a satisfactory level of haemostasis has reduced the use of blood products to treat bleeding episodes. Clinicians need to become familiar with the use of this drug that has become a home medication for many patients with inherited bleeding disorders.Keywords
This publication has 25 references indexed in Scilit:
- Oral Contraceptives and DDAVP Nasal Spray: Patterns of Use in Managing vWD-Associated MenorrhagiaJournal of Pediatric Hematology/Oncology, 2005
- ADAMTS13 turns 3Blood, 2005
- von Willebrand's disease and menorrhagia: Prevalence, diagnosis, and managementAmerican Journal of Hematology, 2005
- The role of PFA‐100® testing in the investigation and management of haemostatic defects in children and adultsBritish Journal of Haematology, 2005
- von Willebrand disease and women’s healthSeminars in Hematology, 2005
- Biologic response to desmopressin in patients with severe type 1 and type 2 von Willebrand disease: results of a multicenter European studyBlood, 2004
- DDAVP (desmopressin; 1-deamino-cys-8- d-arginine-vasopressin) treatment in children with haemophilia BBritish Journal of Haematology, 2000
- Vasopressin Agonists and AntagonistsHormone Research, 1990
- DESMOPRESSIN AND THROMBOSISThe Lancet, 1989
- DDAVP: A useful alternative to blood components in moderate hemophilia A and von Willebrand diseaseThe Journal of Pediatrics, 1983